Clinical Significance [fndg]    
Cell Cycle [celf]    
Apoptosis Marker [bacs]    
Related [qlco]    
Biliary Tract Cancer [neop]    
Tissue Microarray [resd]    
Based [ftcn]    
Approach [spco]    
revealing [qlco]    
Immunophenotype [lbpr]    
Intrahepatic [spco]    
Extrahepatic Cholangiocarcinomas [neop]    
second Malignant tumour [neop]    
LIVER [bpoc]    
Cell Cycle [celf]    
Apoptosis Marker [bacs]    
Related [qlco]    
Cholangiocarcinomas [neop]    
Intrahepatic [spco]    
Extrahepatic [spco]    
gall bladder carcinoma [neop]    
Combined [qlco]    
Tissue Microarray [resd]    
Available [ftcn]    
Patients [podg]    
Comparison [acty]    
Normal Tissue [tisu]    
specimens [sbst]    
Cholangiocarcinomas [neop]    
Frequently [tmco]    
P53 [gngm]    
Bcl-2 [gngm]    
Intrahepatic [spco]    
Tumors [neop]    
Frequently [tmco]    
Bcl-2 [gngm]    
p16 [gngm]    
Extrahepatic [spco]    
Tumors [neop]    
Often [tmco]    
P53 [gngm]    
Loss [qnco]    
p16 [gngm]    
Reduced [qlco]    
Survival [acty]    
Patients [podg]    
P53 [gngm]    
Bcl-2 [gngm]    
Important [qlco]    
pathogenesis [ftcn]    
Cholangiocarcinomas [neop]    
Differential [qlco]    
p16 [gngm]    
Bcl-2 [gngm]    
P53 [gngm]    
Intrahepatic [spco]    
Extrahepatic [spco]    
Tumors [neop]    
Demonstrates [acty]    
Location [spco]    
Related [qlco]    
Phenotype [orga]    
genetic profile [lbpr]    
Tumors [neop]    
p16 [gngm]    
Identified [qlco]    
Important [qlco]    
Prognostic Marker [qlco]    
Cholangiocarcinomas [neop]    
